Don't Ignore This Chart!

Merck Propels XLV Higher


With help from component Merck, the Healthcare SPDR (XLV) bounced off support around 28. The ETF established support here with reaction lows in early September, early October and now early November. It is safe to say that the trend is clearly up as long as this support level holds.

Click this chart for details.

Arthur Hill
About the author: , CMT, is the Chief Technical Strategist at Focusing predominantly on US equities and ETFs, his systematic approach of identifying trend, finding signals within the trend, and setting key price levels has made him an esteemed market technician. Arthur has written articles for numerous financial publications including Barrons and Stocks & Commodities Magazine. In addition to his Chartered Market Technician (CMT) designation, he holds an MBA from the Cass Business School at City University in London. Learn More
Subscribe to Don't Ignore This Chart! to be notified whenever a new post is added to this blog!
comments powered by Disqus